A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells.
Nature. 2022 Mar;603(7900):328-334. doi: 10.1038/s41586-022-04439-0. Epub 2022 Feb 23.
Nature. 2022.
PMID: 35197632